Patients
Physicians
Sites
Sponsors
About Us
Blog
Sites access
Onco access
EN
Last updated 4 days ago
Share
Study of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy
26 patients around the world
Available in
Brazil, United States
Lexeo Therapeutics
5
Research sites
26
Patients around the world
This study is for people with
Ataxia
Friedreich's ataxia
Requirements for the patient
From 6 Years
All Gender
Medical requirements
Inclusion criteria
Male or female, age at least 6 years at the time of signing the informed consent (and assent, if applicable).
Diagnosis of FA, based on clinical phenotype and genotype (GAA expansion on the frataxin gene).
Onset of FA on or before 25 years of age.
Confirmed left ventricular hypertrophy and abnormal left ventricular mass index.
Left ventricular ejection fraction at least 30%.
Anti-AAVrh.10 total antibody titer less than the protocol-specified maximum level.
Exclusion criteria
Presence of other forms of cardiomyopathy that contribute to heart failure.
Current use of inotrope infusion or presence of a ventricular assist device.
Contraindication to cardiac MRI.
Prior organ transplant.
Previous gene transfer or cell therapy.
Poorly controlled diabetes (hemoglobin A1c ≥8%).
Active hematologic or solid organ cancer.
Sites
Hospital Universitário Walter Cantídio - Universidade Federal do Ceará - Fortaleza, Ceara
Consult
View site
R. Coronel Nunes de Melo, 1142 - Rodolfo Teófilo, Fortaleza - CE, 60430-275, Brazil
View site
Consult
Hospital São Rafael
Consult
View site
Av. São Rafael, 2152 - São Marcos, Salvador - BA, 41253-190
View site
Consult
Hospital Das Clínicas Da Universidade Federal de Minas Gerais - UFMG
Consult
View site
Av. Prof. Alfredo Balena, 110 2 floor - Room 216 - Santa Efigênia, Belo Horizonte - MG, 30130-100
View site
Consult
Hospital de Clínicas - Universidade Estadual de Campinas - UNICAMP
Consult
View site
R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888
View site
Consult
Hospital das Clínicas de Ribeirão Preto
Consult
View site
Campus Universitário S/N, Bloco G Subsolo II, Monte Alegre, Ribeirão Preto, Sao Paulo
View site
Consult
See details
Contact us
Contact us
Study
SUNRISE-FA 2
Sponsor
Lexeo Therapeutics
Study type
Interventional
Conditions
Friedreich's ataxia
Requirements
From 6 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT07721025
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
Careers
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent